CYP2C9 Genotype and Pharmacodynamic Responses to Losartan in Patients With Primary and Secondary Kidney Diseases
European Journal of Clinical Pharmacology - Germany
doi 10.1007/s00228-009-0707-7
Full Text
Open PDFAbstract
Available in full text
Date
August 11, 2009
Authors
Publisher
Springer Science and Business Media LLC